Early Access — free while we kick the tires
EdgarHawk

Carroll Jill

Director

Director

Latest: Director buying · May 2026

1 filing analyzed · 1 company · Latest 2026-05-01

Companies

Company Buys Sells Direction
Avalyn Pharma Inc. AVLN 3 0 Net buying

Activity

May 2026
2026-05-01 Avalyn Pharma Inc. AVLN
high
Buy
277,778 shares
$5,000,004
Significance 7/10

Director Jill Carroll buys 277,778 shares of AVLN at $18.00 ($5.0M); cluster of 2 other insiders also buying

Director Jill Carroll purchased 277,778 shares at $18.00 on 2026-05-01 for $5,000,004.00, increasing her holdings by 14.6% to 2,186,562 shares post-transaction. This purchase occurs in the context of a cluster buy pattern, with 2 other insiders also acquiring shares within the past 14 days. The filing also references derivative securities conversions (Table II), indicating this director holds a broader position than the Table I equity shares alone. The substantial $5.0M buy into a recently listed stock (2 trading days old) by multiple insiders within a tight timeframe merits investor attention as a potential signal of insider confidence in the early-stage public position.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access